(Q40430867)

20 September 2017

Systemic administration of attenuated Salmonella choleraesuis in combination with cisplatin for cancer therapy (English)

1 reference

20 September 2017

1 reference

Salmonella choleraesuis

object named as

Salmonella choleraesuis

1 reference

Che-Hsin Lee

1

1 reference

20 September 2017

Chao-Liang Wu

series ordinal

2

1 reference

20 September 2017

Yun-Sheng Tai

series ordinal

3

1 reference

20 September 2017

Ai-Li Shiau

series ordinal

4

1 reference

20 September 2017

1 May 2005

1 reference

20 September 2017

1 reference

20 September 2017

11

1 reference

20 September 2017

5

1 reference

20 September 2017

707-716

1 reference

Bacteria as tumour-targeting vectors

20 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.008

Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.008

Endostatin gene therapy delivered by Salmonella choleraesuis in murine tumor models.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.008

Systemic administration of attenuated Salmonella choleraesuis carrying thrombospondin-1 gene leads to tumor-specific transgene expression, delayed tumor growth and prolonged survival in the murine melanoma model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.008

Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: selective inhibitor of angiogenesis and hypoxic tumor growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.008

Tumor-targeted Salmonella expressing cytosine deaminase as an anticancer agent.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.008

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.008

Prothymosin alpha enhances protective immune responses induced by oral DNA vaccination against pseudorabies delivered by Salmonella choleraesuis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.008

Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.008

THE IMMUNIZATION OF MICE, CALVES AND PIGS AGAINST SALMONELLA DUBLIN AND SALMONELLA CHOLERAE-SUIS INFECTIONS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.008

Combination of low-dose cisplatin and recombinant xenogeneic endoglin as a vaccine induces synergistic antitumor activities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.008

A peptide derived from the non-receptor-binding region of urokinase plasminogen activator inhibits glioblastoma growth and angiogenesis in vivo in combination with cisplatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.008

Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.008

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.008

Cisplatin augments cytotoxic T-lymphocyte-mediated antitumor immunity in poorly immunogenic murine lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.008

Antitumor Activity of Polymorphonuclear Leukocytes Activated by a .BETA.-1,3-D-Glucan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.008

Effect of picibanil (OK432) on neutrophil-mediated antitumor activity: implication of monocyte-derived neutrophil-activating factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.008

A constitutive cytoprotective pathway protects endothelial cells from lipopolysaccharide-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.008

Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.008

Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.008

Positron emission tomography (PET) imaging of tumor-localized Salmonella expressing HSV1-TK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.008

Antitumor effects in mice of the intravenous injection of attenuated Salmonella typhimurium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.008

Combination bacteriolytic therapy for the treatment of experimental tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.01.008

10.1016/J.YMTHE.2005.01.008

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference